Ovarian Carcinosarcoma: Effects of Cytoreductive Status and Platinum-Based Chemotherapy on Survival

Table 1

Clinicopathologic and treatment characteristics. Statistics are reported in median with ranges and percentages.

Factor	𝑁	Statistics
Median age^a	47	66 (20, 88) years
Median preoperative CA-125^a	32	117 (16, 986) units/mL
Stage^b
I/II	11	23.4%
III	27	57.4%
IV	6	12.9%
Unknown	3	6.4%
Cytoreductive status^b
No residual disease	24	51.1%
Less than 1 cm residual disease	9	19.1%
More than 1 cm residual disease	14	29.8%
Lymph node dissection^b
No	34	72.3%
Yes	13	27.7%
Adjuvant therapy^b
Platinum-based chemotherapy	22	46.8%
Nonplatinum-based chemotherapy	13	27.7%
Radiation therapy	3	6.4%
Unknown	9	19.1%

^aRange (minimum, maximum); ^bpercentage.